153 related articles for article (PubMed ID: 17065665)
21. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
[TBL] [Abstract][Full Text] [Related]
22. Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.
Ismail IS; Nazaimoon W; Mohamad W; Letchuman R; Singaraveloo M; Hew FL; Shuguna C; Khalid BA
Diabet Med; 2001 Jun; 18(6):501-8. PubMed ID: 11472471
[TBL] [Abstract][Full Text] [Related]
23. The impact of financial barriers on access to care, quality of care and vascular morbidity among patients with diabetes and coronary heart disease.
Parikh PB; Yang J; Leigh S; Dorjee K; Parikh R; Sakellarios N; Meng H; Brown DL
J Gen Intern Med; 2014 Jan; 29(1):76-81. PubMed ID: 24078406
[TBL] [Abstract][Full Text] [Related]
24. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002.
Saaddine JB; Cadwell B; Gregg EW; Engelgau MM; Vinicor F; Imperatore G; Narayan KM
Ann Intern Med; 2006 Apr; 144(7):465-74. PubMed ID: 16585660
[TBL] [Abstract][Full Text] [Related]
25. [Quality of care and extent of complications in a population-based sample of patients with type 2 diabetes mellitus. The KORA Survey 2000].
Icks A; Rathmann W; Haastert B; Mielck A; Holle R; Löwel H; Giani G; Meisinger C;
Dtsch Med Wochenschr; 2006 Jan; 131(3):73-8. PubMed ID: 16418944
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
Gonzélez C; Stern MP; Mitchell BD; Valdez RA; Haffner SM; Pérez BA
Diabetes Care; 1994 May; 17(5):397-404. PubMed ID: 8062606
[TBL] [Abstract][Full Text] [Related]
27. Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): study design and research methodology.
Agarwal S; Raman R; Paul PG; Rani PK; Uthra S; Gayathree R; McCarty C; Kumaramanickavel G; Sharma T
Ophthalmic Epidemiol; 2005 Apr; 12(2):143-53. PubMed ID: 16019696
[TBL] [Abstract][Full Text] [Related]
28. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service.
McCord AD
Pharmacotherapy; 2006 Feb; 26(2):248-53. PubMed ID: 16466329
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.
Ahmad Khan H
Acta Diabetol; 2007 Dec; 44(4):193-200. PubMed ID: 17786383
[TBL] [Abstract][Full Text] [Related]
30. Glycemic and non-glycemic targets in younger and older North Indian subjects with type 2 diabetes in a Tertiary care hospital: A 10 year's retrospective data analysis.
Ahmad J; Zubair M; Malik N; D Z; Raghav A
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S130-4. PubMed ID: 26564028
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control.
Tan CE; Chew LS; Chio LF; Tai ES; Lim HS; Lim SC; Jayakumar L; Eng HK; Packard CJ
Diabetes Res Clin Pract; 2001 Feb; 51(2):107-14. PubMed ID: 11165690
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of patients reaching the targets of good control in normal clinical practice. A cohort-based study in type 2 diabetes.
Bo S; Cavallo-Perin P; Gentile L
Diabetes Care; 1999 Dec; 22(12):2092. PubMed ID: 10587855
[No Abstract] [Full Text] [Related]
33. HbA(1c) levels in cardiovascular diseased patients without diabetes in a developing country.
Sharma TK; Parchwani H; Kaushik GG; Shankar V; Dahiya K; Ghalaut VS; Sharma N
Clin Lab; 2011; 57(7-8):517-22. PubMed ID: 21888015
[TBL] [Abstract][Full Text] [Related]
34. [La educación multimedia como apoyo en el manejo de pacientes con diabetes tipo 2. Estudio cuasi experimental].
Aguila IP; Velázquez-López L; Goycochea-Robles MAV; Angulo-Angulo F; Peña JE
Cir Cir; 2018; 86(5):404-411. PubMed ID: 30226499
[TBL] [Abstract][Full Text] [Related]
35. Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014.
Tran AT; Bakke Å; Berg TJ; Gjelsvik B; Mdala I; Nøkleby K; Shakil Rai A; Cooper JG; Claudi T; Løvaas K; Thue G; Sandberg S; Jenum AK
Scand J Prim Health Care; 2018 Jun; 36(2):170-179. PubMed ID: 29717939
[TBL] [Abstract][Full Text] [Related]
36. [Validation of the German Diabetes Risk Score with metabolic risk factors for type 2 diabetes].
Schulze MB; Boeing H; Häring HU; Fritsche A; Joost HG
Dtsch Med Wochenschr; 2008 Apr; 133(17):878-83. PubMed ID: 18415912
[TBL] [Abstract][Full Text] [Related]
37. HEMOGLOBIN A1C, BLOOD PRESSURE, AND LDL-CHOLESTEROL CONTROL AMONG HISPANIC/LATINO ADULTS WITH DIABETES: RESULTS FROM THE HISPANIC COMMUNITY HEALTH STUDY/STUDY OF LATINOS (HCHS/SOL).
Casagrande SS; Aviles-Santa L; Corsino L; Daviglus ML; Gallo LC; Espinoza Giacinto RA; Llabre MM; Reina SA; Savage PJ; Schneiderman N; Talavera GA; Cowie CC
Endocr Pract; 2017 Oct; 23(10):1232-1253. PubMed ID: 28816530
[TBL] [Abstract][Full Text] [Related]
38. Sex and age differences in the achievement of control targets in patients with type 2 diabetes: results from a population-based study in a South European region.
Cambra K; Galbete A; Forga L; Lecea O; Ariz MJ; Moreno-Iribas C; Aizpuru F; Ibañez B
BMC Fam Pract; 2016 Oct; 17(1):144. PubMed ID: 27729015
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial.
Ménard J; Payette H; Baillargeon JP; Maheux P; Lepage S; Tessier D; Ardilouze JL
CMAJ; 2005 Dec; 173(12):1457-66. PubMed ID: 16293781
[TBL] [Abstract][Full Text] [Related]
40. Poor glycemic control is an independent risk factor for low HDL cholesterol in patients with type 2 diabetes.
Gatti A; Maranghi M; Bacci S; Carallo C; Gnasso A; Mandosi E; Fallarino M; Morano S; Trischitta V; Filetti S
Diabetes Care; 2009 Aug; 32(8):1550-2. PubMed ID: 19487641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
